NOVEL PURIFIED FABI POLYPEPTIDES FROM FRANSICELLA TULARENSIS

The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CLARKE, TERESA, BERMAN, JUDD, M, DORSEY, MANDY, BEATTIE, BRYAN, AWREY, DONALD, E, SCHMID, PH. D., MOLLY, B
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention. La présente invention se rapporte à de nouvelles cibles médicamenteuses destinées à lutter contre des bactéries pathogènes. Ainsi, l'invention concerne une protéine purifiée renfermant la séquence d'acides aminés représentée par SEQ ID NO: 2. L'invention a également trait à des caractéristiques biochimiques et biophysiques des polypeptides selon l'invention.